Sangamo Therapeutics (SGMOQ) Market Capitalization (2010 - 2025)

Sangamo Therapeutics has reported Market Capitalization for 16 years, with the latest figure at $117.7 million in Q4 2025.

• On a quarterly basis, Market Capitalization fell 45.79% year-over-year to $117.7 million in Q4 2025; TTM through Dec 2025 was $117.7 million, a 45.79% decrease from a year earlier, with the FY2025 full-year figure at $117.7 million, down 45.79% from the prior year.
• Market Capitalization was $117.7 million for Q4 2025 at Sangamo Therapeutics, down from $225.5 million in the prior quarter.
• The five-year high for Market Capitalization was $1.8 billion in Q1 2021, with the low at $75.0 million in Q2 2024.
• Average Market Capitalization over 5 years is $539.2 million, with a median of $227.8 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2023: Market Capitalization soared 143.86% in 2021, then sank 86.75% in 2023.
• Over 5 years, Market Capitalization stood at $1.1 billion in 2021, then tumbled by 52.14% to $523.7 million in 2022, then tumbled by 81.63% to $96.2 million in 2023, then surged by 125.69% to $217.1 million in 2024, then plunged by 45.79% to $117.7 million in 2025.
• The last three Market Capitalization figures came in at $117.7 million (Q4 2025), $225.5 million (Q3 2025), and $162.9 million (Q2 2025), per Business Quant data.